Screening for caspase-3 inhibitors: A new class of potent small-molecule inhibitors of caspase-3

22Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

From the authors' 650,000 compound collection, they have selected approximately 15,000 potential small-molecule protease inhibitors, which were subjected to high-throughput screening against caspase-3. The screening yielded a series of hits that belong to 11 different scaffolds. Based on the structure of one of the hits, a new class of the small-molecule inhibitors with a double electrophilic warhead, 8-sulfonyl-pyrrolo[3,4-c]quinoline-1,3-diones (SPQ), was synthesized and tested in follow-up mechanistic and antiapoptosis assays. Mechanistic analysis of a representative compound of this class, CD-001-0011, showed that the compound exhibited a high potency (IC50 =130 nM), was reversible though noncompetitive, and had a broad selectivity profile to other caspases belonging to groups I to III. The compound was effective in preventing staurosporine-induced apoptosis in a few cell lines and retinoic acid-induced apoptosis in zebrafish. © 2006 Society for Biomolecular Sciences.

Cite

CITATION STYLE

APA

Okun, I., Malarchuk, S., Dubrovskaya, E., Khvat, A., Tkachenko, S., Kysil, V., … Ivachtchenko, A. (2006). Screening for caspase-3 inhibitors: A new class of potent small-molecule inhibitors of caspase-3. Journal of Biomolecular Screening, 11(3), 277–285. https://doi.org/10.1177/1087057105285048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free